X-108150219-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_052936.5(ATG4A):c.882G>A(p.Thr294Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00497 in 1,210,278 control chromosomes in the GnomAD database, including 174 homozygotes. There are 1,623 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 89 hom., 785 hem., cov: 23)
Exomes 𝑓: 0.0028 ( 85 hom. 838 hem. )
Consequence
ATG4A
NM_052936.5 synonymous
NM_052936.5 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: -1.15
Genes affected
ATG4A (HGNC:16489): (autophagy related 4A cysteine peptidase) Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This gene encodes a member of the autophagin protein family. The encoded protein is also designated as a member of the C-54 family of cysteine proteases. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant X-108150219-G-A is Benign according to our data. Variant chrX-108150219-G-A is described in ClinVar as [Benign]. Clinvar id is 769183.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0867 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG4A | NM_052936.5 | c.882G>A | p.Thr294Thr | synonymous_variant | 10/13 | ENST00000372232.8 | NP_443168.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG4A | ENST00000372232.8 | c.882G>A | p.Thr294Thr | synonymous_variant | 10/13 | 1 | NM_052936.5 | ENSP00000361306.3 |
Frequencies
GnomAD3 genomes AF: 0.0257 AC: 2888AN: 112196Hom.: 89 Cov.: 23 AF XY: 0.0227 AC XY: 780AN XY: 34370
GnomAD3 genomes
AF:
AC:
2888
AN:
112196
Hom.:
Cov.:
23
AF XY:
AC XY:
780
AN XY:
34370
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00790 AC: 1450AN: 183457Hom.: 43 AF XY: 0.00524 AC XY: 356AN XY: 67899
GnomAD3 exomes
AF:
AC:
1450
AN:
183457
Hom.:
AF XY:
AC XY:
356
AN XY:
67899
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00284 AC: 3116AN: 1098029Hom.: 85 Cov.: 31 AF XY: 0.00231 AC XY: 838AN XY: 363389
GnomAD4 exome
AF:
AC:
3116
AN:
1098029
Hom.:
Cov.:
31
AF XY:
AC XY:
838
AN XY:
363389
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0258 AC: 2895AN: 112249Hom.: 89 Cov.: 23 AF XY: 0.0228 AC XY: 785AN XY: 34433
GnomAD4 genome
AF:
AC:
2895
AN:
112249
Hom.:
Cov.:
23
AF XY:
AC XY:
785
AN XY:
34433
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at